金融界9月26日消息，2024年上半年，高视医疗实现收入642.0百万元，相较于2023年同期的700.7百万元减少8.4%。同期，公司净利润为26.9百万元，同比下降75.6%，由2023年同期的110.4百万元降至26.9百万元。每股基本盈利为0.19元，较上一年同期的0.75元减少了显著。研发支出从2023年同期的26.1百万元增长34.5%，达到35.1百万元，在收入中所占比率从3.7%增至5.5%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.